<--- Back to Details
First PageDocument Content
Medicine / Pharmacology / Clinical research / Pharmaceutical industry / Pharmaceuticals policy / Federal Food /  Drug /  and Cosmetic Act / Clinical trial / New Drug Application / Investigational New Drug / Food and Drug Administration / Pharmaceutical sciences / Health
Medicine
Pharmacology
Clinical research
Pharmaceutical industry
Pharmaceuticals policy
Federal Food
Drug
and Cosmetic Act
Clinical trial
New Drug Application
Investigational New Drug
Food and Drug Administration
Pharmaceutical sciences
Health

#173 Guidance for Industry Animal Drug Sponsor Fees under the Animal Drug User Fee Act (ADUFA) This guidance discusses how the Food and Drug Administration intends to implement the animal drug sponsor fee provision of AD

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 51,92 KB

Share Document on Facebook

Similar Documents

PROUD PROUD Participant Involvement meeting: Trial Design Date: Tuesday 9th September – 20.00 Venue: MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, Holborn, WC2B 6NH Contact person: Mitzy Gaf

PROUD PROUD Participant Involvement meeting: Trial Design Date: Tuesday 9th September – 20.00 Venue: MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, Holborn, WC2B 6NH Contact person: Mitzy Gaf

DocID: 1vq4y - View Document

Clinical Review & Education  JAMA | Special Communication Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

Clinical Review & Education JAMA | Special Communication Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

DocID: 1vmrb - View Document

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

DocID: 1vkmw - View Document

DEPARTMENT OF HEALTH DRUG OFFICE DRUG REGISTRATION AND IMPORT/EXPORT CONTROL DIVISION Guidance Notes on the Application for Certificate for Clinical Trial/Medicinal Test Background

DEPARTMENT OF HEALTH DRUG OFFICE DRUG REGISTRATION AND IMPORT/EXPORT CONTROL DIVISION Guidance Notes on the Application for Certificate for Clinical Trial/Medicinal Test Background

DocID: 1vkj3 - View Document

CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and

CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and

DocID: 1vbDv - View Document